These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30919133)

  • 21. Assessing Amyloid Pathology in Cognitively Normal Subjects Using
    Collij LE; Konijnenberg E; Reimand J; Kate MT; Braber AD; Lopes Alves I; Zwan M; Yaqub M; van Assema DME; Wink AM; Lammertsma AA; Scheltens P; Visser PJ; Barkhof F; van Berckel BNM
    J Nucl Med; 2019 Apr; 60(4):541-547. PubMed ID: 30315145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementing the centiloid transformation for
    Bourgeat P; Doré V; Fripp J; Ames D; Masters CL; Salvado O; Villemagne VL; Rowe CC;
    Neuroimage; 2018 Dec; 183():387-393. PubMed ID: 30130643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of Tau Load Using [
    Golla SSV; Timmers T; Ossenkoppele R; Groot C; Verfaillie S; Scheltens P; van der Flier WM; Schwarte L; Mintun MA; Devous M; Schuit RC; Windhorst AD; Lammertsma AA; Boellaard R; van Berckel BNM; Yaqub M
    Mol Imaging Biol; 2017 Dec; 19(6):963-971. PubMed ID: 28374171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET.
    Ory D; Postnov A; Koole M; Celen S; de Laat B; Verbruggen A; Van Laere K; Bormans G; Casteels C
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):163-172. PubMed ID: 26323575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data.
    Lundqvist R; Lilja J; Thomas BA; Lötjönen J; Villemagne VL; Rowe CC; Thurfjell L
    J Nucl Med; 2013 Aug; 54(8):1472-8. PubMed ID: 23740104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients.
    Sonni I; Fazio P; Schain M; Halldin C; Svenningsson P; Farde L; Varrone A
    J Nucl Med; 2016 Oct; 57(10):1529-1534. PubMed ID: 27230923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [
    Smart K; Uribe C; Desmond KL; Martin SL; Vasdev N; Strafella AP
    Mol Imaging; 2023; 2023():1855985. PubMed ID: 37622164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.
    Baker SL; Lockhart SN; Price JC; He M; Huesman RH; Schonhaut D; Faria J; Rabinovici G; Jagust WJ
    J Nucl Med; 2017 Feb; 58(2):332-338. PubMed ID: 27587706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
    Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P
    J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of the quantitative accuracy of low-dose amyloid and tau PET imaging.
    Nai YH; Watanuki S; Tashiro M; Okamura N; Watabe H
    Radiol Phys Technol; 2018 Dec; 11(4):451-459. PubMed ID: 30328073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
    J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
    Barthel H; Gertz HJ; Dresel S; Peters O; Bartenstein P; Buerger K; Hiemeyer F; Wittemer-Rump SM; Seibyl J; Reininger C; Sabri O;
    Lancet Neurol; 2011 May; 10(5):424-35. PubMed ID: 21481640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
    Ikonomovic MD; Buckley CJ; Heurling K; Sherwin P; Jones PA; Zanette M; Mathis CA; Klunk WE; Chakrabarty A; Ironside J; Ismail A; Smith C; Thal DR; Beach TG; Farrar G; Smith AP
    Acta Neuropathol Commun; 2016 Dec; 4(1):130. PubMed ID: 27955679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
    Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic Modeling of the Tau PET Tracer
    Barret O; Alagille D; Sanabria S; Comley RA; Weimer RM; Borroni E; Mintun M; Seneca N; Papin C; Morley T; Marek K; Seibyl JP; Tamagnan GD; Jennings D
    J Nucl Med; 2017 Jul; 58(7):1124-1131. PubMed ID: 27908967
    [No Abstract]   [Full Text] [Related]  

  • 37. [
    Stenzel J; Rühlmann C; Lindner T; Polei S; Teipel S; Kurth J; Rominger A; Krause BJ; Vollmar B; Kuhla A
    Curr Alzheimer Res; 2019; 16(1):49-55. PubMed ID: 30345916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patlak plot based on the first 30 minutes post-injection dynamic
    Oliveira FP; Ferreira SM; Silva MG; Castanheira JC; Teixeira RJ; Costa DC
    Br J Radiol; 2022 Oct; 95(1139):20211023. PubMed ID: 36069339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
    Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
    J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [(18)F]Florbetaben: a review in β-amyloid PET imaging in cognitive impairment.
    Syed YY; Deeks E
    CNS Drugs; 2015 Jul; 29(7):605-13. PubMed ID: 26175116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.